This Helped Apollo Hospitals Report An ‘All-Round Performance’ In Q2
WATCH | Group CFO Krishnan Akhileswaran on Apollo Hospitals’ Q2 Results
India’s largest hospital chain said it witnessed an “all-round performance” in the quarter ended September, mainly aided by volumes.
The performance was healthy across incumbent (mature) hospitals as well as new branches, according to Krishnan Akhileswaran, group chief financial officer at Apollo Hospitals Enterprise Ltd. The cardiac, oncology, orthopedics and neurosciences departments performed well, he told BloombergQuint.
The hospital chain saw a revenue growth of around 14 percent in the Chennai cluster, 12 percent in Hyderabad, 17 percent in Bengaluru, 14 percent in Calcutta, 11 percent in Delhi, and 10 percent in Ahemdabad, Akhileswaran said. “Overall, the quarter has been good for us. The top line grew by almost 18 percent (year-on-year) to Rs 2,463 crore. Healthcare services grew 15 percent and standalone pharmacies grew 22 percent.”
Akhileswaran also said that the average revenue per occupied bed is now Rs 3,982, a growth of 10 percent. That’s because of “our focus on the centres of excellence and an increase in laparoscopic cases and non-invasive surgeries across our systems”.
Apollo Hospitals Q2 Results: Key Highlights (YoY)
- Revenues up 18 percent to Rs 2,841 crore.
- Net profit up 54 percent to Rs 83 crore.
- Ebitda up 52 percent to Rs 413 crore.
- Margin at 14.5 percent against 11.3 percent.
On Friday, Apollo Hospitals’ shares fell 1.67 percent to Rs 1,394.25 apiece on the BSE while the benchmark Sensex gained 0.17 percent to end the day at 40,356.69 points.